Deerfield Management Mergers and Acquisitions Summary

Private Equity Profile

In the last 3 years, Deerfield Management has acquired 1 company. It has also invested in 1 other.

Deerfield Management’s most common sector for investment is life science (100%). The Firm’s most common investment types include divestiture (50%) and growth capital (50%). In total, Deerfield Management has invested in 1 US state and 2 different countries. Its largest (disclosed) acquisition occurred in 2018 when it acquired Nuvo Pharmaceuticals - TOPROL-XL for $140M.

Join Mergr to view Deerfield Management’s full profile and discover more mega-sized private equity firms just like it.

M&A Summary

  • M&A Total Activity2
    • M&A Buy Activity2
  • Total Sectors Invested 1
  • Total Countries Invested 2
  • M&A Buy/Sell Connections 1

Deerfield Management

,
www.deerfield.com

Deerfield Management is a hedge fund sponsor focused on public and private company investments in the healthcare sector. Deerfield was established in 1994 and is headquartered in New York City.


Investment Criteria

Sectors of Interest: Healthcare Services, Life Science, Medical Products

Target Transaction Types: Buyout (LBO, MBO, MBI), Growth Capital

Geographic Preferences: East US, Midwest US, South US, West US

Transaction Criteria Min Max
Target Revenue - -
Target EBITDA - -
Investment Size - -
Enterprise Value - -

M&A Summary

Buy vs Sell

Year ≤ '15 '16 '17 '18 '19 '20 T
Buy (0.4/yr) # - - - 2 - - 2
vol $140M $140M
Sell (0.0/yr) # - - - - - - 0
  2

Most Recent M&A

Company Date Value Type
Nuvo Pharmaceuticals, Inc. - TOPROL-XL 2018-08-10 140M USD Divestiture
Mississauga, Ontario
Ablexis LLC 2018-06-21 - Growth Capital
San Francisco, California · www.ablexis.com
View All >>

M&A by Sector

Sector Current # Value All-time # Value
Life Science 2 (100%) 140M (100%) 2 (100%) 140M (100%)
Total 2 $140M 2 $140M

Acquisitions By Geo

State/Country Current # Value All-time # Value
Canada 1 (50%) 140M (100%) 1 (50%) 140M (100%)
  Ontario 1 (50%) 140M (100%) 1 (50%) 140M (100%)
United States 1 (50%) - 1 (50%) -
  California 1 (50%) - 1 (50%) -
Total 2 $140M 2 $140M

Acquisitions by Deal Type

Type Current # Value All-time # Value
Divestiture 1 (50%) 140M (100%) 1 (50%) 140M (100%)
Growth Capital 1 (50%) - 1 (50%) -
Total 2 $140M 2 $140M

Deal Values

buy # Total
$100M to $1B 1 $140M
TOTAL $140M
Largest Nuvo Pharmaceuticals, Inc. - TOPROL-XL
$140M (2018-08-10)

M&A Connections

Deals %
Acquired from
Strategic(s)
100%
1 100%